Depsipeptide for therapy of kidney cancer
US8673888B2 · kind B2 · utility
0Cited by
3References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 27, 2003 |
| Grant date | Mar 18, 2014 |
| Priority date | — |
| Expiry date | Dec 30, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a therapeutic agent of kidney cancer, which comprises FK228 of the formula (I) or a salt thereof. FK228 or a salt thereof, which is an active ingredient in the present invention, shows a superior antitumor activity in vivo against kidney cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.